Impact_Report_2019_Flipping_BK

Funds are often used to cover the research time of posts within the team to undertake research activity that has the potential to improve the treatment, outcome and experiences of people affected by lymphoma. Research at The Christie has benefitted patients not just in Greater Manchester, but the world. Dr Kim Linton, Senior Lecturer and Honorary Consultant in Medical Oncology, said “It is thanks to generous donations that the lymphoma team has been able to expand and take all important research from the lab to the bedside.” “Without the support of the charity we recognise that we would be unable to attract the best talent or develop new treatments – therefore, we would be unable to improve patient outcomes as successfully as we do. The charity allows us to ensure funding is continuous and bridges gaps where without it we would need to halt essential research.” The breakthroughs of the lymphoma team simply would not have happened without charitable investment and we need to keep that momentum going if we are going to save even more lives in the future.

The Christie’s lymphoma team has an international reputation in clinical trials to improve patient outcomes. Donations to the team have allowed it to expand research activity, further enhancing the treatment opportunities and latest clinical trials offered to our lymphoma patients.

32

33